SCTX
Scribe Therapeutics, Inc. · Healthcare · Market cap $563.0M
Insiders bought $71.3M net in the last 90 days ·0 sellers, 6 buyers· latest Form 4 filed Jul 29, 2026
Insider Buying
$71.3M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Jul 29, 2026
AH Bio Fund II, L.P.
Scribe Therapeutics, Inc. (SCTX) has 7 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 29, 2026.
Inside the rolling window, 6 insiders at Scribe Therapeutics, Inc. reported 7 open-market purchases totaling $71.3M and no open-market sales. Insiders have net bought $71.3M over the trailing 6 months. The largest single insider purchase in this window was $36.1M by Director, 10% Owner Aghazadeh Behzad on Jul 24, 2026. The most recent open-market filing is a purchase of 333,333 shares by 10% Owner AH Bio Fund II, L.P., dated Jul 27, 2026, worth $5.0M.
- Industry:Biotechnology
- CEO:Benjamin L. Oakes
- HQ:Alameda, CA, US
- IPO:2026-07-24
| Source | |||||||
|---|---|---|---|---|---|---|---|
AH Bio Fund II, L.P.First filing | 10% Owner | Purchase | 333,333 | $5.0M | Jul 29 | cluster+62.0% | SEC ↗ |
GORDON CARL LFirst filing | Director | Purchase | 1,000,000 | $15.0M | Jul 29 | cluster+62.0% | SEC ↗ |
| Director | Purchase | 1,000,000 | $15.0M | Jul 29 | cluster+62.0% | SEC ↗ | |
Aghazadeh BehzadFirst filing | See Remarks | Purchase | 2,383,333 | $36.1M | Jul 29 | cluster+62.0% | SEC ↗ |
Aghazadeh BehzadFirst filing | See Remarks | Purchase | 7,905 | $144K | Jul 29 | cluster+62.0% | SEC ↗ |
Lucas SvetlanaFirst in 10 months | Chief Business Officer | Purchase | 3,000 | $45K | Jul 28 | cluster+64.7% | SEC ↗ |
Parrot DavidFirst filing | Chief Financial Officer | Purchase | 1,333 | $20K | Jul 28 | cluster+64.7% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does SCTX have?
Scribe Therapeutics, Inc. (SCTX) has 7 SEC Form 4 filings (14 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Jul 29, 2026.
When was the most recent SEC Form 4 filing for SCTX?
The most recent Form 4 filing for SCTX on Tracefour is dated Jul 29, 2026.
What is the net insider flow at SCTX over the last 6 months?
Over the trailing 180 days, insiders at SCTX have net bought $71.3M based on SEC Form 4 disclosures.
What was the largest insider purchase at SCTX?
The largest single insider open-market purchase at SCTX in the rolling window was $36.1M by Director, 10% Owner Aghazadeh Behzad on 2026-07-24.
What is the total insider buy and sell value at SCTX in the current window?
Inside the rolling window, insiders at SCTX bought $71.3M and sold $0 based on SEC Form 4 filings.
Can I get alerts for SCTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Scribe Therapeutics, Inc. (SCTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Scribe Therapeutics, Inc. is in the Healthcare sector.